Daniel W. Lee

11.1k citations

60 papers · 4.7k indexed · 3 hit papers · h-index 26

Impact in

Oncology top 0.5%
- CAR-T cell therapy research
Immunology top 2%
- Immune Cell Function and Interaction

Papers in

Oncology 42
- CAR-T cell therapy research 42
Endocrine and Autonomic Systems 4

Co-authors: Crystal L. Mackall Stephan A. Grupp Michael C. Jensen Chrystal U. Louis David Porter Rebecca Gardner Nabil Ahmed Nirali N. Shah
Journals: Blood (15 papers)Blood Advances (4 papers)Transplantation and Cellular Therapy (4 papers)Regulatory Peptides (3 papers)Cancer Research (3 papers)
Partner nations: United States France Malaysia

In The Last Decade

Daniel W. Lee

58 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL 2021 · 200 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of Clinical Oncology
2014 Blood
2012 Blood

Peers

Countries citing papers authored by Daniel W. Lee

Since Specialization

Citations

This map shows the geographic impact of Daniel W. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Lee more than expected).

Fields of papers citing papers by Daniel W. Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Lee. The network helps show where Daniel W. Lee may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel W. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel W. Lee Line = papers co-authored together Daniel W. Lee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acquired CAR-T Therapy Resistance in a Pre-Clinical Model of Pediatric Rhabdomyosarcoma Minimal Residual Disease Transplantation and Cellular Therapy ·Каримова Марворит Олимовна, Dustin Cobb, 苏龙, Husin Nanang, Lixia Liu, Daniel W. Lee	2025	0
2	Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells Journal for ImmunoTherapy of Cancer ·Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey W. Taub, R. Hunt, Dana L. Schalk, 岱周, Saur Sariaty Pasaribu, Harshita Rai, Daniel W. Lee, Qin Liu, Anthony F. Shields, Nai‐Kong V. Cheung, Lawrence G. Lum	2024	12
3	A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials Blood Advances ·Sara Silbert, Sanna Madan, エリコーヘン, Seth M. Steinberg, Lauren Little, Toni Foley, Monica Epstein, Сыроватко Елена Ивановна, Daniel W. Lee, J. R. Shepard, Đoàn Thị Nhung, Eytan Ruppin, Haneen Shalabi, Bonnie Yates, Nirali N. Shah	2023	2
4	The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes Blood Advances ·徐麗淑, John A. Ligon, こず恵斉藤, Seth M. Steinberg, Toni Foley, Lauren Little, Crystal L. Mackall, Daniel W. Lee, Terry J. Fry, Haneen Shalabi, Jennifer N. Brudno, Bonnie Yates, Lekha Mikkilineni, James N. Kochenderfer, Nirali N. Shah	2022	25
5	Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia Haematologica ·Alan S. Wayne, Van Huynh, Nobuko Hijiya, Rayne H. Rouce, Patrick A. Brown, Joerg Krueger, Carrie L. Kitko, Leandra Raquel Carneiro Sabino, Michelle L. Hermiston, Michael K. Richards, André Baruchel, Petra Schuberth, John M. Rossi, Fanny Rosselot, Lovely Goyal, Rajul K. Jain, Remus Vezan, Behzad Kharabi Masouleh, Daniel W. Lee	2022	26
6	Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days Blood Advances ·Lekha Mikkilineni, Bonnie Yates, Seth M. Steinberg, Shilpa Shahani, John C. Molina, Tara N. Palmore, Daniel W. Lee, Rosandra N. Kaplan, Crystal L. Mackall, Terry J. Fry, Juan Gea‐Banacloche, 张四保, Véronique Nussenblatt, James N. Kochenderfer, Nirali N. Shah	2021	47
7	Factors Impacting Overall and Event-Free Survival following Post-Chimeric Antigen Receptor T Cell Consolidative Hematopoietic Stem Cell Transplantation Transplantation and Cellular Therapy ·John C. Molina, Seth M. Steinberg, Bonnie Yates, Daniel W. Lee, Lauren Little, Crystal L. Mackall, Haneen Shalabi, Nirali N. Shah	2021	12
8	Characterization of extramedullary disease in B-ALL and response to CAR T-cell therapy Blood Advances ·エリコーヘン, Bonnie Yates, Alexander Ling, Constance M. Yuan, Hao‐Wei Wang, Maryalice Stetler‐Stevenson, P Poulter-Friesen, John C. Molina, Daniel A. Lichtenstein, Daniel W. Lee, John A. Ligon, Haneen Shalabi, Mark A. Ahlman, Nirali N. Shah	2021	35
9	Long-Term Follow-Up of CD19-CAR T-Cell Therapy in Children and Young Adults With B-ALL Journal of Clinical Oncology ·Nirali N. Shah, Daniel W. Lee, Bonnie Yates, Constance M. Yuan, Haneen Shalabi, Staci Martin, Pamela L. Wolters, Seth M. Steinberg, Eva H. Baker, Cindy Delbrook, Maryalice Stetler‐Stevenson, Terry J. Fry, David F. Stroncek, Crystal L. Mackall Hit paper breakdown →	2021	200
10	Low CD19 Antigen Density Diminishes Efficacy of CD19 CAR T Cells and Can be Overcome By Rational Redesign of CAR Signaling Domains Blood ·Robbie G. Majzner, Skyler P. Rietberg, Louai Labanieh, Elena Sotillo, Evan W. Weber, Rachel C. Lynn, Johanna Theruvath, Constance M. Yuan, Peng Xu, Sang M. Nguyen, Nirali N. Shah, Maryalice Stetler‐Stevenson, Terry J. Fry, Daniel W. Lee, Crystal L. Mackall	2018	7
11	Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells Journal for ImmunoTherapy of Cancer ·Anandani Nellan, Christopher Rota, Robbie G. Majzner, Shusheng Leng, Andrea M. Griesinger, Jean M. Mulcahy Levy, Nicholas K. Foreman, Katherine E. Warren, Daniel W. Lee	2018	102
12	Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells Journal of Translational Medicine ·David F. Stroncek, Daniel W. Lee, Jiaqiang Ren, Marianna Sabatino, Steven L. Highfill, Hanh Khuu, Nirali N. Shah, Rosandra N. Kaplan, Terry J. Fry, Crystal L. Mackall	2017	55
13	Long-Term Outcomes Following CD19 CAR T Cell Therapy for B-ALL Are Superior in Patients Receiving a Fludarabine/Cyclophosphamide Preparative Regimen and Post-CAR Hematopoietic Stem Cell Transplantation Blood ·Daniel W. Lee, Maryalice Stetler‐Stevenson, Constance M. Yuan, Nirali N. Shah, Cindy Delbrook, Bonnie Yates, Hua Zhang, Ling Zhang, James N. Kochenderfer, Steven A. Rosenberg, Terry J. Fry, David Stroncek, Crystal L. Mackall	2016	90
14	Paving the road ahead for CD19 CAR T-cell therapy Current Opinion in Hematology ·Anandani Nellan, Daniel W. Lee	2015	12
15	Simplified process for the production of anti–CD19-CAR–engineered T cells Cytotherapy ·Barbara Tumaini, Daniel W. Lee, Tim Chong, Luciano Castiello, David F. Stroncek, Crystal L. Mackall, Alan S. Wayne, Marianna Sabatino	2013	87
16	Muslin-induced intracranial vasculopathic stenosis: A report of two cases Clinical Neurology and Neurosurgery ·Daniel W. Lee, Mandy J. Binning, Victoria K. Shanmugam, Richard H. Schmidt, William T. Couldwell, Maximilian A. Meyer, Thomas R. Cupps, Carlos Romero, Kevin M. McGrail	2011	9
17	Embolotherapy of Pulmonary Arteriovenous Malformations with Detachable Balloons: Long-term Durability and Efficacy Journal of Vascular and Interventional Radiology ·Sanjay Saluja, Madison Alayne Hinton, Daniel W. Lee, Jeffrey Pollak, Robert I. White	1999	53
18	Embolotherapy of Large Pulmonary Arteriovenous Malformations: Long-Term Results The Annals of Thoracic Surgery ·Daniel W. Lee, Robert I. White, T K Egglin, Jeffrey Pollak, Pierre Fayad, Joel A. Wirth, Melvin Rosenblatt, Kevin W. Dickey, Nancy Aracely Ambrocio Ángeles	1997	220
19	Human Follicular Fluid Contains a Follicle-Stimulating Hormone (FSH) Receptor Binding Inhibitor Which Has FSH Agonist Activity, is Immunologically Similar to FSH, But Can Be Distinguished from FSH* The Journal of Clinical Endocrinology & Metabolism ·Daniel W. Lee, William J. Butler, A.E. Cover, Robert M. Shelden, LEO E. REICHERT	1991	10
20	Identification of low and high molecular weight follicle-stimulating hormone receptor-binding inhibitors in human follicular fluid Fertility and Sterility ·Daniel W. Lee, Robert M. Shelden, LEO E. REICHERT	1990	14

About Daniel W. Lee

Daniel W. Lee is a scholar working on Oncology, Endocrine and Autonomic Systems, Neurology, Public Health, Environmental and Occupational Health and Nutrition and Dietetics, having authored 60 papers that have together received 4.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (42 papers), Acute Lymphoblastic Leukemia research (12 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers), Neuroblastoma Research and Treatments (7 papers), Virus-based gene therapy research (6 papers), Biochemical Analysis and Sensing Techniques (6 papers), Immune Cell Function and Interaction (5 papers) and Silicon Carbide Semiconductor Technologies (5 papers). The work is most often cited by research in Oncology (3.4k citations), Immunology (937 citations), Genetics (437 citations), Genetics (971 citations) and Hematology (382 citations). Daniel W. Lee has collaborated with scholars based in United States, France and Malaysia. Frequent co-authors include Crystal L. Mackall, Stephan A. Grupp, Michael C. Jensen, Chrystal U. Louis, David Porter, Rebecca Gardner, Nabil Ahmed, Crystal L. Mackall, Nirali N. Shah and Terry J. Fry. Their work appears in journals such as Blood, Blood Advances, Transplantation and Cellular Therapy, Regulatory Peptides and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact